BioSpace News Archive

First-in-human clinical trial of novel, selective thyroid receptor ß agonist for X-ALD

Phio Pharmaceuticals Corp. announced that its chief executive officer, Dr. Gerrit Dispersyn, will present at the upcoming H.C. Wainwright 22nd Annual Global Investment Conference, held virtually this year from September 14 – 16, 2020.

Targeted, in-office suprachoroidal delivery of RGX-314 using the SCS Microinjector® may provide additional administration options for patients with wet AMD

Valted Seq has created the world’s largest repository of single-cell sequencing data from the brain tissue of patients with neurodegenerative diseases including Alzheimer’s and Parkinson’s

Adagio Therapeutics, Inc., a company focused on the development of best-in-class antibodies to provide broad protection against SARS-CoV-2, SARS-CoV-1 and additional circulating bat coronaviruses, announced it has strengthened its management team with the addition of Eric Kimble as Chief Commercial Officer and Ed Campanaro as Senior Vice President of Clinical Operations.

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that its New Drug Submission for BRUKINSA® for the treatment of patients with Waldenström’s macroglobulinemia has been accepted by Health Canada and granted priority review status.

Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster

Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced the appointment of industry veteran Thomas G. Wiggans to its board of directors.

TScan Therapeutics, a biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies in oncology, announced plans to file two Investigational New Drug applications in their liquid tumor program in 2021.

Repare Therapeutics Inc. announced that Lloyd M. Segal, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15 at 10:15 a.m.